Oaktree Acquisition Corp. III Life Sciences (OACC) Free Cash Flow (2025 - 2026)

Oaktree Acquisition Corp. III Life Sciences filings provide 2 years of Free Cash Flow readings, the most recent being -$158035.0 for Q1 2026.

  • Quarterly Free Cash Flow fell 109.15% to -$158035.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$504553.0 through Mar 2026, changed N/A year-over-year, with the annual reading at -$422079.0 for FY2025, 370.61% down from the prior year.
  • Free Cash Flow hit -$158035.0 in Q1 2026 for Oaktree Acquisition Corp. III Life Sciences, down from -$143876.0 in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$56518.0 in Q3 2025 and bottomed at -$158035.0 in Q1 2026.